SummaryThe recent development of treatment modalities for patients with idiopathic pulmonary arterial hypertension has been based on the evaluation of many different markers such as functional capacity, addressed by NYHA classification, six-minute walk test (6MWT) and hemodynamic parameters. The aim of this study was to evaluate the correlation of N-terminal fragment (NT-proBNP) with other markers in IPAH and its potential for patient stratification.We studied 42 IPAH patients consecutively evaluated through right heart catheterization in the absence of any specific treatment for pulmonary hypertension. Blood samples, clinical evaluation and 6MWF distance were collected at baseline.The levels of NT-proBNP showed a high correlation with hemo...
SummaryBackgroundThis study aims to evaluate the role of NT-proBNP and six minute walking distance (...
The aim of the current study was to investigate whether alterations in N-terminal pro brain natriure...
Pulmonary arterial hypertension (PAH) is a progressive disease that requires validated biomarkers of...
SummaryThe recent development of treatment modalities for patients with idiopathic pulmonary arteria...
Background: Right heart catheterization is the gold standard for diagnosing and estimating pulmonary...
N-terminal pro B-type natriuretic peptide (NT-proBNP) is a product of cleavage of the cardiac prohor...
Abstract Background N-terminal pro-brain-type natriuretic peptide (NT-proBNP) is currently used as a...
Background: NT-proBNP (N-terminal pro brain natriuretic peptide) levels are included in the multipar...
Abstract Background While the N-terminal pro-brain-type natriuretic peptide (NT-proBNP) at rest is k...
<div><p>N-terminal pro-brain natriuretic peptide (NT-proBNP) is a routinely used prognostic paramete...
N-terminal pro-brain natriuretic peptide (NT-proBNP) is a routinely used prognostic parameter in pat...
Rationale: NT-proBNP (N-terminal pro–brain natriuretic peptide), a biomarker of cardiac origin, is u...
OBJECTIVE: To assess the association between serially measured N-terminal pro-B-type natriuretic pep...
Rationale: NT-proBNP (N-terminal pro-brain natriuretic peptide), a biomarker of cardiac origin, is u...
Background: This study aims to evaluate the role of NT-proBNP and six minute walking distance (6MWD)...
SummaryBackgroundThis study aims to evaluate the role of NT-proBNP and six minute walking distance (...
The aim of the current study was to investigate whether alterations in N-terminal pro brain natriure...
Pulmonary arterial hypertension (PAH) is a progressive disease that requires validated biomarkers of...
SummaryThe recent development of treatment modalities for patients with idiopathic pulmonary arteria...
Background: Right heart catheterization is the gold standard for diagnosing and estimating pulmonary...
N-terminal pro B-type natriuretic peptide (NT-proBNP) is a product of cleavage of the cardiac prohor...
Abstract Background N-terminal pro-brain-type natriuretic peptide (NT-proBNP) is currently used as a...
Background: NT-proBNP (N-terminal pro brain natriuretic peptide) levels are included in the multipar...
Abstract Background While the N-terminal pro-brain-type natriuretic peptide (NT-proBNP) at rest is k...
<div><p>N-terminal pro-brain natriuretic peptide (NT-proBNP) is a routinely used prognostic paramete...
N-terminal pro-brain natriuretic peptide (NT-proBNP) is a routinely used prognostic parameter in pat...
Rationale: NT-proBNP (N-terminal pro–brain natriuretic peptide), a biomarker of cardiac origin, is u...
OBJECTIVE: To assess the association between serially measured N-terminal pro-B-type natriuretic pep...
Rationale: NT-proBNP (N-terminal pro-brain natriuretic peptide), a biomarker of cardiac origin, is u...
Background: This study aims to evaluate the role of NT-proBNP and six minute walking distance (6MWD)...
SummaryBackgroundThis study aims to evaluate the role of NT-proBNP and six minute walking distance (...
The aim of the current study was to investigate whether alterations in N-terminal pro brain natriure...
Pulmonary arterial hypertension (PAH) is a progressive disease that requires validated biomarkers of...